This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Rheuma-Forschungszentrum Berlin. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Sascha Rutz
Introduction
Sascha Rutz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patent related to interleukin-22 modulation. His work has implications for treating infections and related illnesses.
Latest Patents
Sascha Rutz holds a patent titled "Methods of modulating interleukin-22 and immune response by notch regulators." This invention focuses on the use of notch regulators to modulate IL-22 production in T-cells. By influencing the activity of the notch signaling pathway, his invention aims to enhance the immune response, especially during infection reactions. Furthermore, it addresses the reduction of IL-22 production in T-cells, which can be crucial for treating various infection-associated illnesses. He has 1 patent to his name.
Career Highlights
Throughout his career, Sascha Rutz has worked with prominent organizations such as Deutsches Rheuma-Forschungszentrum Berlin and Miltenyi Biotec GmbH. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Sascha has collaborated with notable colleagues, including Alexander Scheffold and Frederick Heinrich. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Sascha Rutz's contributions to immunology through his patent on interleukin-22 modulation highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for improving treatment options for infections.